Nanocarriers for Delivery of Anticancer Drugs: Current Developments, Challenges, and Perspectives

Nanocarriers for Delivery of Anticancer Drugs: Current Developments, Challenges, and Perspectives

Cancer, the most common condition worldwide, ranks second in terms of the number of human deaths, surpassing cardiovascular diseases. Uncontrolled cell multiplication and resistance to cell death are the traditional features of cancer. The myriad of treatment options include surgery, chemotherapy, r...

Full description

Saved in:
Bibliographic Details
Main Authors: Umme Hani, Vikram T. Choudhary, Mohammed Ghazwani, Yahia Alghazwani, Riyaz Ali M. Osmani, Gururaj S. Kulkarni, Hosakote G. Shivakumar, Shahid Ud Din Wani, Sathishbabu Paranthaman
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Pharmaceutics
Subjects:
cancer
drug delivery
nanomedicine
tumor metabolism
mRNA therapy
Online Access:https://www.mdpi.com/1999-4923/16/12/1527
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1999-4923/16/12/1527

Similar Items